We administer a vector containing cancer-suppressing genes or a vector incorporating siRNA to inhibit cancer-proliferation genes (gene therapy proteins) via intravenous drip every 1 to 4 weeks. In the first cycle, gene therapy proteins are administered five times, each time with 8 units. In the second cycle, gene therapy proteins are administered five times, each time with 10 units. This type of gene therapy is applicable to various types of cancer, including pancreatic cancer, lung cancer, colorectal cancer, gallbladder cancer, breast cancer, and gastric cancer. Side effects are minimal. The director has experience with gene therapy in several hundred cancer patients, and depending on the type and stage of cancer, it has shown curative, remission, or life-extending effects. This treatment can be performed concurrently with standard treatments such as surgery, chemotherapy, and radiation therapy.
requirement, condition for apply
Target Diseases・Disease Status：
Pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, breast cancer, uterine cancer, bladder cancer, kidney cancer, liver cancer, and more
for more details information about this program, kindly inquire from here
